Advertisements

Advantix Hund

Quick links to important sections

Advantix Hund

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Advantix Hund

What is Advantix Hund? An Identity Overview

Property Description
Active Ingredients Imidacloprid, Permethrin
Form Spot-on solution (Topical liquid)
Pharmacological Class Ectoparasiticide (Antiparasitic agent)
Target Species Dogs (Canine species only)
Origin Synthetic (Combination product)

Advantix Hund is a widely recognized veterinary medicinal product that functions as an ectoparasiticide intended exclusively for the canine species. As a combination product, it contains two distinct, synthetic active chemical entities, Imidacloprid and Permethrin, which provide its therapeutic effect. This dual-ingredient preparation is manufactured by Elanco, distinguishing it through its specific formulation and proprietary spot-on delivery system. The official classification places the drug under the ATCvet code QP53AC54.

Composition and Physical Form: The Dual-Action Spot-on Solution

The medicine’s identity is founded on its two active ingredients, Imidacloprid and Permethrin. Imidacloprid is derived from the chloronicotinyl nitroguanidine group, while Permethrin is classified as a Type I pyrethroid, highlighting the distinct chemical origins and dual targeting nature of the formulation. Advantix Hund is supplied as a spot-on solution, a specific dosage form designed solely for dermal or external use. This liquid preparation utilizes an oily solvent base, including medium-chain triglycerides, to facilitate the non-systemic distribution of the active substances across the dog's skin and coat surface following topical application.

General Purpose: Lethal and Repellent Ectoparasitic Control

The general purpose of Advantix Hund is the control and prevention of external parasitic infestations on dogs through its potent dual-action mechanism. The combination of Imidacloprid and Permethrin is recognized for its ability to prevent the transmission of certain vector-borne diseases by controlling the parasite population. This means the formulation provides both a rapid insecticide and acaricide effect (lethal action against various arthropods) and, critically, a distinct repellent capability (anti-feeding action) provided largely by the Permethrin component, which actively discourages new external pests from successfully reaching the treated canine.

Advertisements

What side effects are possible with Advantix Hund?

Official Adverse Reactions and Safety Profile

The safety profile of this medicine is classified by official regulatory documents based on the frequency and type of documented adverse reactions. These effects are organized according to physiological system, reflecting standard pharmacovigilance reporting.

Classification Examples of Reactions
Uncommon Transient application site pruritus (itching) or scratching, local hair changes (e.g., greasy appearance), and vomiting.
Rare Application site erythema (redness), hair loss (alopecia), local inflammation, and diarrhoea.
Very Rare General signs such as lethargy, agitation, or neurological signs, including tremor and unsteady movement, which typically occur following inadvertent oral uptake.

Adverse reactions are primarily associated with Skin and Subcutaneous Tissue Disorders (local reactions) and Gastrointestinal Disorders. Neurological signs are categorized under Nervous System Disorders and are generally described as transient and self-resolving.

Critical Safety Constraints and Contraindications

The official label documents specific safety limitations and absolute contraindications. The most critical constraint is the absolute toxicity to cats; the product is extremely poisonous to the feline species and its use in cats is strictly forbidden due to their physiological inability to metabolize the permethrin component. To prevent serious harm, treated dogs must be kept separate from cats until the application site is fully dry.

Usage is also restricted by population: the product is contraindicated for use in puppies less than seven weeks of age or those weighing under 1.5 kg. Furthermore, due to extreme toxicity to aquatic organisms, treated dogs must be prevented from entering any surface water for at least 48 hours following application.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Advantix Hund (imidacloprid and permethrin) is generally safe for dogs when used according to the prescribed dosage, which is based on the dog's body weight. An overdose, often resulting from applying the wrong size pipette, using a product not approved for dogs, or accidental oral ingestion (such as licking the application site), can lead to toxicity.

Since there is no specific antidote for Advantix Hund toxicity, treatment is strictly symptomatic and supportive. Therefore, immediate veterinary attention is critical if an overdose is suspected.

Severity Potential Symptoms Action
Mild to Moderate Excessive drooling (hypersalivation), paw flicking, ear twitching, vomiting, diarrhea, lethargy, skin irritation at the application site. Contact your veterinarian for advice. You may be instructed to bathe the dog with a mild detergent and cool water to remove the product from the skin.
Severe Muscle tremors, uncoordinated movement (ataxia), restlessness, seizures, difficulty breathing, collapse. Seek emergency veterinary care immediately. Stabilization and supportive measures (e.g., intravenous fluids, muscle relaxants, temperature regulation) will be required.

Preventing overdose is achieved by carefully following the instructions, never using a product intended for larger dogs on a smaller dog, and ensuring the application site is dry before the dog can lick it or contact another pet.

Advertisements

Therapeutic Uses of Advantix Hund

What Advantix Hund Treats: Main Uses and Benefits

Advantix Hund is commonly used across two core therapeutic domains: managing external parasites and contributing to the reduction of risks associated with vector-borne diseases.


Immediate Relief from Ectoparasite Infestation Symptoms

This treatment is applied in clinical settings that involve acute symptom patterns caused by the presence of fleas, ticks, and biting lice that create noticeable physiological strain. It helps address symptom clusters related to pruritus (itching) and localized skin irritation. The product is commonly used to help manage symptomatic relief across key domains, including addressing existing infestations by fleas and biting lice, as well as the control of several species of ticks. By managing the presence of ectoparasites, the treatment contributes to improved day-to-day comfort, assisting with maintaining functional stability and helping to ease the overall symptom burden of biting nuisance.


Prevention of Vector-Borne Disease Risk and FAD Management

A vital use is its relevance in situations requiring assistance in reducing the risk of transmitting serious systemic conditions, such as Canine Leishmaniosis and Canine Ehrlichiosis. It is relevant in areas where the control of vectors like sand flies and specific ticks is important for risk reduction. Furthermore, it is applied in chronic conditions like Flea Allergy Dermatitis (FAD), and is used in conditions where control of flea presence is central to managing the resulting hypersensitivity skin reactions and provides supportive relief for the associated chronic lesions.

Quick Fact: Relief for Pruritus
The product is commonly used to help manage the severe itching and discomfort associated with flea bites in dogs with Flea Allergy Dermatitis (FAD), and supports general well-being during symptomatic phases.

Regulatory References

  1. Irish Health Products Regulatory Authority Summary of Product Characteristics for Advantix
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Advantix Hund? — Official Regulatory Information

The eligibility for Advantix Hund (Imidacloprid/Permethrin) is strictly defined by regulatory authorities based on species, health status, and age/weight thresholds.


Contraindications and Absolute Exclusions

The product is absolutely contraindicated for use in cats as the permethrin component is toxic and potentially fatal to felines. It must not be used in any dog with a known hypersensitivity to the active substances or any of the product's excipients.


Age and Health Restrictions

Category Regulatory Status
Target Species Dogs (Canine species)
Minimum Age/Weight Not for use on puppies less than 7 weeks of age or those weighing less than 1.5 kg (EU/UK labeling), as safety is not established below these limits.
Pregnancy/Lactation Can be used during pregnancy and lactation.
Conditional Use Veterinary consultation is advised before use in sick or debilitated dogs.

These constraints ensure the product is used only where its safety profile is established and regulatory approval has been granted.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction scope

The interaction profile for Advantix Hund is primarily constrained by its active ingredients and topical application, rather than complex systemic drug interactions. The medicinal product categories with officially documented interaction-related constraints are other topical/dermal treatments. Regulatory labels confirm that no interactions have been observed when administered with commonly used systemic veterinary medicinal products, such as vaccines, antibiotics, or anthelmintics. No specific interacting systemic medicines are listed in official regulatory documents.

Interaction classifications (high-level)

The interaction severity classification is defined as Contraindicated regarding co-exposure with non-target species. The regulatory basis for this profile stems from Summary of Product Characteristics (SmPC) documentation, which defines the interaction context constraints. The primary constraint is the strict species-specific prohibition and the requirement to maintain the integrity of the active ingredients on the skin surface.

Resulting interaction structure

Official interaction statements:

  • The product is contraindicated for use in cats due to the severe, life-threatening Permethrin toxicity.
  • Administration must be separated by time from shampooing or the application of other dermal treatments.
  • No interactions have been observed with commonly used systemic veterinary medicinal products when administered at the recommended dose.

Connection to the overall interaction profile: The official regulatory documentation establishes a specific interaction structure focusing on external constraints: a mandatory species-specific prohibition and a necessary timing separation rule for co-administration with topical products. This structure is consistent with the product's design as a topical ectoparasiticide with minimal risk of systemic drug-drug interactions.

Advertisements

Mechanism of Action

Advantix Hund operates via a dual-mechanism neurotoxicity delivered by Imidacloprid and Permethrin, targeting distinct and vital parts of the arthropod nervous system. The contact-based action results in a swift sequence of physiological failures in target parasites.

Disruption of Arthropod Synaptic Communication

Imidacloprid acts as a selective partial agonist on post-synaptic Nicotinic Acetylcholine Receptors (nAChRs) in the insect's central nervous system. This interaction leads to the persistent activation and subsequent irreversible functional blockade of synaptic nerve impulse transmission. This molecular failure quickly escalates to CNS dysfunction and paralysis.

Modulation of Axonal Impulse Conduction

Permethrin acts as a kinetic modulator that binds to Voltage-Gated Sodium Channels ( Nav) along the nerve axons. By delaying the channel's inactivation, Permethrin causes prolonged sodium influx, resulting in repetitive nerve firing and intense hyperexcitation followed by paralysis. This specific mechanism results in a Na^+ channel modification pattern that underlies both the observed acaricidal activity and the anti-feeding physiological response.

Complementary Neurotoxicity and Selectivity Constraints

The combination results in complementary neurotoxicity by attacking both the central synaptic junction and the peripheral impulse conduction simultaneously. Selectivity arises from the agents' low affinity for mammalian receptors compared to arthropod receptors. The mechanism's functional constraint is exemplified by the physiological consequences of poor Permethrin metabolism in felines, specifically a lack of necessary hepatic glucuronidase enzymes, which prolongs the agent's action on Nav channels in that species.

Advertisements

Dosage and Administration Information

How to Use Advantix Hund

Advantix Hund is designed exclusively for dermal or topical use as a spot-on solution. Application must be restricted to the undamaged skin of the dog. The product is administered in fixed volumes selected according to the dog's body weight to ensure delivery of the minimum recommended dose of 10 mg/kg body weight (bw) Imidacloprid and 50 mg/kg bw Permethrin.


Dosing and Frequency

The standard pattern for maintenance is monthly application (once every four weeks) to achieve sustained control. However, official guidance allows for retreatment not more frequently than once weekly if the dog experiences frequent, intense exposure to water that may reduce the product's persistence. Treatment is not approved for use in puppies less than 7 weeks of age or those below the specified weight threshold for the smallest pipette size.

Weight Band Pipette Volume Minimum Dose Achieved
le 4 kg 0.4 ml 10 mg/kg Imidacloprid
>4 kg le 10 kg 1.0 ml 50 mg/kg Permethrin

Administration Technique

The entire volume of the selected pipette must be applied. For dogs le 10 kg, the contents are applied to one spot between the shoulder blades. For dogs >10 kg, the contents are applied evenly to four spots along the back, from the shoulder to the base of the tail. The hair must be parted at each site until the skin is visible. To ensure correct usage, precautions are required to prevent licking or oral uptake by the treated animal or other pets until the application site is completely dry.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Advantix Hund

Evidence for Use in Flea Infestation Control

Research exploring Advantix Hund was studied for flea infestations and has included both randomized controlled laboratory studies and controlled field trials. These studies primarily focused on measuring the change in adult flea counts following application and assessing the time taken to eliminate existing flea populations.

Research examined outcomes related to physical discomfort in dogs, including those with Flea Allergy Dermatitis (FAD). Studies explored how symptoms such as pruritus (itching) and localized skin irritation were monitored in the observed populations. Findings describe patterns measured in the studies related to a reduction of the flea burden and how irritative states were tracked.

Evidence for Use in Tick Control and Prevention

Research exploring Advantix Hund was studied for tick control and prevention, utilizing controlled laboratory challenge studies and field trials. These studies monitored two primary effects: the acaricidal (tick-killing) effect, measured by the reduction in attached live tick counts, and the repellent effect, assessed by the product's ability to prevent various hard tick species from attaching.

Studies describe the effects observed in the studies against different species of hard ticks. Data describe patterns related to both the killing and anti-attachment effects, with measurements taken through the standard four-week re-treatment interval.

Evidence for Reducing Risk of Vector-Borne Diseases

Research explored the product's role in reducing the risk of systemic conditions, such as Canine Leishmaniosis and Canine Ehrlichiosis, which are transmitted by vectors like sand flies and ticks. Research primarily explored the repellent effect against sand flies using controlled laboratory studies, and field trials tracked pathogen markers in dogs in disease-endemic areas.

These findings contribute to the broader evidence landscape related to reducing risk. However, the risk reduction measurement is dependent on the consistent maintenance of the primary repellent effect; the research provides context but not individual predictions of prevention.

Long-Term Research and Durability of Effect

Studies generally focused on short-term symptom changes and efficacy measurements over the standard four-week re-treatment period. Follow-up durations were therefore typically limited to this interval in the controlled studies. Data for certain groups remain limited when considering the needs of continuous treatment over many months or years. Long-term effects are not fully established regarding the durability of the killing and repellent actions beyond the single-dose monitoring period.

Key Studies & References

  1. SUMMARY OF PRODUCT CHARACTERISTICS (Advantix 600 mg + 3000 mg spot-on solution for dogs) - Veterinary Medicines Directorate (VMD/EMA regulatory document)
  2. Efficacy of a combination of 10% imidacloprid/50% permethrin for the prevention of leishmaniasis in kennelled dogs in an endemic area
  3. Comparative Efficacy of a Combination of Fipronil/(S)-Methoprene, a Combination of Imidacloprid/Permethrin, and Imidacloprid Against Fleas and Ticks When Administered Topically to Dogs
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Advantix Hund (FAQ)

Q: What types of external parasites is Advantix Hund officially indicated to protect against?

According to regulatory product information, Advantix Hund is officially indicated for mixed infestations by several external parasites, including fleas, biting lice, ticks, sand flies, mosquitoes, and stable flies. It is intended for use when simultaneous protection against all these species is required.

Q: What is the expected onset time for the product's effect after application?

Official documents indicate that the product is observed to begin working quickly. Fleas on the dog are observed to be killed within one day (24 hours) following treatment. Ticks are also generally observed to be killed and will fall off the host within 24 to 48 hours following infestation, as a rule.

Q: Is Advantix Hund still effective if the dog is exposed to water, such as swimming or rain?

The official product information indicates that Advantix Hund does remain effective even if the animal becomes wet from rain or a quick dip. However, to maintain persistent efficacy, official guidance suggests avoiding prolonged or intense exposure to water. The frequency of water exposure may reduce how long the treatment lasts.

Q: What information is available regarding Advantix Hund's ability to help with biting flies?

The official documentation notes that Advantix Hund offers repellent (anti-feeding) activity against stable flies, which are a type of biting fly. This protective effect against stable flies is expected to last for four weeks after a single application.

Q: Why might a pet owner still see live ticks or fleas on their dog shortly after application?

Regulatory information acknowledges that the attachment of individual ticks may still occur even after treatment has been applied. The official data indicates that any attached ticks are observed to be killed and typically fall off the host within 24 to 48 hours.

Q: Is there a stated timeframe for when application site irritations should normally disappear?

Official regulatory documents describe local and general temporary reactions, such as mild itching or agitation, as 'transient and self-resolving.' While a specific timeframe is not provided, this phrasing indicates that such effects are not expected to be lasting.

Q: What specific precautions are officially advised for humans handling the dog after Advantix Hund has been applied?

Official guidance recommends that humans avoid contact between the product and their skin, eyes, or mouth, and wash hands thoroughly after application. It is also required that treated dogs be kept away from cats until the application site is completely dry to prevent accidental exposure to the cat.

Q: Can Advantix Hund cause staining on household materials like fabric or wood?

The official label information states that the solvent in the product may cause discolouration or damage to certain household materials, such as leather, fabrics, plastics, and finished surfaces. To avoid this, it is advised to ensure the application site is completely dry before the dog comes into contact with these items.

Q: Is Advantix Hund suitable for dogs with pre-existing skin conditions?

Official product information notes that the product is intended for application only to undamaged skin. If the dog is sick or debilitated, regulatory guidance suggests consulting with a veterinary surgeon before applying the product.

Q: What is the minimum recommended time period for separating cats from a dog treated with Advantix Hund?

To prevent serious toxic effects, the product label requires treated dogs to be kept separated from cats until the application site is fully dry. Regulatory documents mention reports of toxicity in cats that came into contact with treated dogs up to 48 hours after application.

Q: Is it generally safe to use Advantix Hund in a multi-pet household with other animals?

Regarding multi-pet households, regulatory information notes that if other animals (besides cats) in the house have parasites, they can be a source of re-infection. The label notes that treating these other pets with a suitable product may be considered to fully control the environmental parasitic burden.

Q: What is the guidance if Advantix Hund solution accidentally splashes into a human's eye or mouth?

If the Advantix Hund solution accidentally splashes into a human's eye or mouth, regulatory first aid measures apply. If the product is in the eyes, the product information specifies washing them out immediately with water. If swallowed, the requirement is to contact a poison control center or physician.

Q: What is the general advice if the Advantix Hund solution makes contact with the owner's skin during application?

Official safety precautions state that direct contact between the product and the owner's skin is to be avoided during application. In the event of accidental spillage onto the skin, the product information recommends washing the area off immediately with soap and water.

Q: Does Advantix Hund work effectively if the solution is primarily on the dog's hair rather than the skin?

Advantix Hund is formulated as a spot-on solution for external use. The product is required to be applied only to the dog's undamaged skin. The instructions for proper application require parting the hair to ensure that the solution successfully reaches the skin surface.

Q: Is there information on whether Advantix Hund should be used throughout the year, regardless of the season?

Regulatory documents suggest that the decision to use the product, including whether to use it year-round, should be based on the local risk of infestation. This involves confirming the presence and type of parasites or the risk level based on environmental and regional factors for each individual animal.

Advertisements

How should Advantix Hund be stored and disposed of?

Storage and Disposal of Advantix Spot-on Solution

Mandatory Storage Conditions

Advantix Spot-on Solution must be stored at a temperature not exceeding 30°C and must be protected from freezing. The product should be kept in a dry place and stored in the original, sealed foil pouch until use.

Stability and Safety

The full shelf-life applies to the product stored in its sealed container. After removing a pipette from the pouch, it must be used immediately or within a short period as specified on the label. The product must be stored out of the sight and reach of children and pets.

Official Disposal Rules

Due to its environmental hazard, the unused product must not enter water courses (such as drains or rivers). Disposal of any unused veterinary medicinal product or waste material must be carried out in accordance with local waste requirements; do not pour partly filled product down-the-drain. Empty containers should be disposed of in the trash or recycled.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Advantix Hund found in:

A-Z Index: